Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration
Heng Du1, Lan Guo1, Xiaoping Wu2
1Department of Pharmacology and Toxicology, and Higuchi Bioscience Center, School of Pharmacy, University of Kansas, Lawrence, KS 66047, USA.
Abstract:
The coexistence of neuronal mitochondrial pathology and synaptic dysfunction is an early pathological feature of Alzheimer's disease (AD). Cyclophilin D (CypD), an integral part of mitochondrial permeability transition pore (mPTP), is involved in amyloid beta (Aβ)-instigated mitochondrial dysfunction. Blockade of CypD prevents Aβ-induced mitochondrial malfunction and the consequent cognitive impairments. Here, we showed the elimination of reactive oxygen species (ROS) by antioxidants probucol or superoxide dismutase (SOD)/catalase blocks Aβ-mediated inactivation of protein kinase A (PKA)/cAMP regulatory-element-binding (CREB) signal transduction pathway and loss of synapse, suggesting the detrimental effects of oxidative stress on neuronal PKA/CREB activity. Notably, neurons lacking CypD significantly attenuate Aβ-induced ROS. Consequently, CypD-deficient neurons are resistant to Aβ-disrupted PKA/CREB signaling by increased PKA activity, phosphorylation of PKA catalytic subunit (PKA C), and CREB. In parallel, lack of CypD protects neurons from Aβ-induced loss of synapses and synaptic dysfunction. Furthermore, compared to the mAPP mice, CypD-deficient mAPP mice reveal less inactivation of PKA-CREB activity and increased synaptic density, attenuate abnormalities in dendritic spine maturation, and improve spontaneous synaptic activity. These findings provide new insights into a mechanism in the crosstalk between the CypD-dependent mitochondrial oxidative stress and signaling cascade, leading to synaptic injury, functioning through the PKA/CREB signal transduction pathway.
Insights
Blocking Cyclophilin D (CypD) prevents amyloid beta-induced mitochondrial dysfunction and synaptic loss in Alzheimer's disease models. This highlights CypD's role in oxidative stress and PKA/CREB pathway disruption, crucial for synaptic health.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Neurodegenerative Diseases
Background:
- Alzheimer's disease (AD) features early neuronal mitochondrial pathology and synaptic dysfunction.
- Cyclophilin D (CypD) is implicated in amyloid beta (Aβ)-induced mitochondrial dysfunction via the mitochondrial permeability transition pore (mPTP).
- CypD inhibition shows potential in preventing Aβ-induced cognitive deficits.
Purpose of the Study:
- To investigate the role of CypD in Aβ-mediated oxidative stress, synaptic dysfunction, and the PKA/CREB signaling pathway.
- To determine if blocking CypD can protect neurons from Aβ-induced synaptic damage.
- To elucidate the mechanism linking mitochondrial oxidative stress to synaptic injury via the PKA/CREB pathway.
Main Methods:
- Utilized antioxidants (probucol, SOD/catalase) to assess the impact of reactive oxygen species (ROS) on neuronal signaling and synapses.
- Examined Aβ-induced changes in CypD-deficient neurons, focusing on ROS levels, PKA/cAMP regulatory-element-binding (CREB) pathway activity, and synaptic integrity.
- Compared CypD-deficient mice expressing amyloid precursor protein (mAPP) with control mAPP mice to evaluate synaptic density, dendritic spine maturation, and synaptic activity.
Main Results:
- Antioxidant treatment blocked Aβ-mediated inactivation of the PKA/CREB pathway and synapse loss, indicating oxidative stress's detrimental effect.
- CypD-deficient neurons exhibited reduced Aβ-induced ROS and were resistant to Aβ-disrupted PKA/CREB signaling, showing increased PKA activity and CREB phosphorylation.
- Lack of CypD protected neurons from Aβ-induced synaptic loss and dysfunction; CypD-deficient mAPP mice displayed improved synaptic density and function compared to controls.
Conclusions:
- CypD-dependent mitochondrial oxidative stress is a key mechanism driving synaptic injury in Alzheimer's disease.
- The PKA/CREB signaling pathway is a critical mediator linking oxidative stress to synaptic dysfunction.
- Targeting CypD offers a potential therapeutic strategy to mitigate mitochondrial dysfunction and synaptic damage in AD.
Related Concept Videos
Anaphase Promoting Complex
Alzheimer Disease ll: Pathophysiology


